Profiel
Yi Liang served as Vice President-Oncology at Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd.
and Vice President at AstraZeneca Pharmaceuticals Co., Ltd.
Prior to that, he was the Chief Commercial Officer & President-Greater China at Zai Lab Ltd.
from 2018 to 2024.
Dr. Liang holds an MBA from China Europe International Business School and a doctorate from Fudan University.
Eerdere bekende functies van Yi Liang
| Bedrijven | Functie | Einde |
|---|---|---|
| ZAI LAB LIMITED | Corporate Officer/Principal | 30-04-2024 |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | - |
AstraZeneca Pharmaceuticals Co., Ltd.
 AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The company believes in the power of science and considers it a top priority in all of its work. | Corporate Officer/Principal | - |
Opleiding van Yi Liang
| Fudan University | Doctorate Degree |
| China Europe International Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
AstraZeneca Pharmaceuticals Co., Ltd.
AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The company believes in the power of science and considers it a top priority in all of its work. | Health Technology |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. |
